# Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity

> **NCT05111067** · — · COMPLETED · sponsor: **Nova Scotia Health Authority** · enrollment: 120 (actual)

## Conditions studied

- Triple Negative Breast Cancer

## Interventions

- **GENETIC:** DNA and whole transcriptome mRNA sequencing

## Key facts

- **NCT ID:** NCT05111067
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05111067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05111067, "Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05111067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*